AQR's reduction to below 5% removes the need for future 13G filings, but the passive nature and small stake size limit any signal. Monitor for any further institutional trimming or conversion to 13D by other holders.
VNDA drugs
VNDA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $3.99entry
- T+1 · 20h ago −4.51%α −2.60% · $3.81
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
AQR Capital Management filed an amended Schedule 13G disclosing a 3.47% passive stake in Vanda Pharmaceuticals as of September 30, 2026, down from a prior filing that did not specify a percentage. The reduction in stake suggests AQR has trimmed its position, though the filing remains passive with no activist intent.
Key Financial Metrics
Key Facts
- AQR Capital Management disclosed a 3.47% passive stake in Vanda Pharmaceuticals as of September 30, 2026
- AQR holds 2,096,939 shares of common stock
- This is an amendment to a prior Schedule 13G filing, indicating a reduction from a previously undisclosed higher stake
- The filing is passive under Rule 13d-1(b), with no activist intent
Financial Impact
AQR's stake reduced to 3.47% from a previously undisclosed level; no dollar value stated
Risk Factors
- AQR's reduction could signal waning institutional conviction, though the stake remains material at 3.47%
- No specific reason for the reduction is provided in the filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001167557-26-000261 |
| Document: 0001167557-26-000261-index.html | 0001167557-26-000261 |
| Document: 0001167557-26-000261.txt | 0001167557-26-000261 |
Track record
8 reports on VNDA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $3.99 Now $3.81 −4.51% settles Nov 20
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $4.08 Now $3.81 −6.62% settles Nov 17
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $4.05 to $3.59 Now $3.81 −5.93% ▼ −11.36% −6.63% vs SPY
- Oct 27, 202620d ago SC 13G Neutral 4/10 Entry $4.00 to $3.88 Now $3.81 −4.75% ▼ −3.00% −2.29% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $4.05 to $4.05 Now $3.81 −5.93% · 0.00% −0.71% vs SPY
- Oct 9, 20265w ago SC 13G/A Neutral 4/10 Entry $4.54 to $4.09 Now $3.81 −16.08% ▼ −9.91% −8.42% vs SPY
- Jul 29, 202615w ago Press Release Neutral 1/10 Entry $5.18 Now $3.81 −26.45% No price data
- May 6, 202627w ago 8-K Mixed 6/10 Entry $6.39 to $6.43 Now $3.81 −40.38% ▲ +0.63% −0.88% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers